These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29707144)

  • 21. Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells.
    Ho SM; Lau KM; Mok SC; Syed V
    Oncogene; 2003 Jul; 22(27):4243-56. PubMed ID: 12833147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Gynecologic Oncology Group study of platinum-DNA adducts and excision repair cross-complementation group 1 expression in optimal, stage III epithelial ovarian cancer treated with platinum-taxane chemotherapy.
    Darcy KM; Tian C; Reed E
    Cancer Res; 2007 May; 67(9):4474-81. PubMed ID: 17483363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of therapeutic efficacy between TP regimen and CBP regimen on epithelial ovarian cancer after optimal cytoreductive operation].
    Gao KF; Liu FY; Chen FJ; Feng YL
    Ai Zheng; 2007 Apr; 26(4):431-4. PubMed ID: 17430668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy.
    Lee SY; Kang HG; Yoo SS; Kang YR; Choi YY; Lee WK; Choi JE; Jeon HS; Shin KM; Oh IJ; Kim KS; Lee J; Cha SI; Kim CH; Kim YC; Park JY
    Lung Cancer; 2013 Nov; 82(2):330-9. PubMed ID: 23973201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene expression for dihydropyrimidine dehydrogenase and thymidine phosphorylase influences outcome in epithelial ovarian cancer.
    Fujiwaki R; Hata K; Nakayama K; Fukumoto M; Miyazaki K
    J Clin Oncol; 2000 Dec; 18(23):3946-51. PubMed ID: 11099324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum-paclitaxel chemotherapy.
    Li Z; Qing Y; Guan W; Li M; Peng Y; Zhang S; Xiong Y; Wang D
    Cancer Chemother Pharmacol; 2014 Oct; 74(4):777-86. PubMed ID: 25107571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Breast Cancer Oncogene EMSY Represses Transcription of Antimetastatic microRNA miR-31.
    Viré E; Curtis C; Davalos V; Git A; Robson S; Villanueva A; Vidal A; Barbieri I; Aparicio S; Esteller M; Caldas C; Kouzarides T
    Mol Cell; 2014 Apr; 54(1):203. PubMed ID: 28898635
    [No Abstract]   [Full Text] [Related]  

  • 28. Clarifying the role of EMSY in DNA repair in ovarian cancer.
    Kondrashova O; Scott CL
    Cancer; 2019 Aug; 125(16):2720-2724. PubMed ID: 31154666
    [No Abstract]   [Full Text] [Related]  

  • 29. Tumor and Cerebrospinal Fluid microRNAs in Primary Central Nervous System Lymphomas.
    Zajdel M; Rymkiewicz G; Sromek M; Cieslikowska M; Swoboda P; Kulinczak M; Goryca K; Bystydzienski Z; Blachnio K; Ostrowska B; Borysiuk A; Druzd-Sitek A; Walewski J; Chechlinska M; Siwicki JK
    Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31731456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IRF6 Is Directly Regulated by ZEB1 and ELF3, and Predicts a Favorable Prognosis in Gastric Cancer.
    Li D; Cheng P; Wang J; Qiu X; Zhang X; Xu L; Liu Y; Qin S
    Front Oncol; 2019; 9():220. PubMed ID: 31019894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxic-stabilized EPAS1 proteins transactivate DNMT1 and cause promoter hypermethylation and transcription inhibition of EPAS1 in non-small cell lung cancer.
    Xu XH; Bao Y; Wang X; Yan F; Guo S; Ma Y; Xu D; Jin L; Xu J; Wang J
    FASEB J; 2018 Jun; ():fj201700715. PubMed ID: 29920222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiomic characterization of high-grade serous ovarian carcinoma: editorial commentary on recent application and consideration for future directions.
    Jones TN; Shih IM; Wang TL
    Transl Cancer Res; 2023 May; 12(5):1368-1371. PubMed ID: 37304548
    [No Abstract]   [Full Text] [Related]  

  • 33. PROM1, CXCL8, RUNX1, NAV1 and TP73 genes as independent markers predictive of prognosis or response to treatment in two cohorts of high-grade serous ovarian cancer patients.
    Dansonka-Mieszkowska A; Szafron LA; Kulesza M; Stachurska A; Leszczynski P; Tomczyk-Szatkowska A; Sobiczewski P; Parada J; Kulinczak M; Moes-Sosnowska J; Pienkowska-Grela B; Kupryjanczyk J; Chechlinska M; Szafron LM
    PLoS One; 2022; 17(7):e0271539. PubMed ID: 35867729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EMSY inhibits homologous recombination repair and the interferon response, promoting lung cancer immune evasion.
    Marzio A; Kurz E; Sahni JM; Di Feo G; Puccini J; Jiang S; Hirsch CA; Arbini AA; Wu WL; Pass HI; Bar-Sagi D; Papagiannakopoulos T; Pagano M
    Cell; 2022 Jan; 185(1):169-183.e19. PubMed ID: 34963055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Ancestry Analysis Reveals Misclassification of Commonly Used Cancer Cell Lines.
    Hooker SE; Woods-Burnham L; Bathina M; Lloyd S; Gorjala P; Mitra R; Nonn L; Kimbro KS; Kittles RA
    Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1003-1009. PubMed ID: 30787054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer.
    Dansonka-Mieszkowska A; Szafron LM; Moes-Sosnowska J; Kulinczak M; Balcerak A; Konopka B; Kulesza M; Budzilowska A; Lukasik M; Piekarska U; Rzepecka IK; Parada J; Zub R; Pienkowska-Grela B; Madry R; Siwicki JK; Kupryjanczyk J
    Oncotarget; 2018 Apr; 9(25):17735-17755. PubMed ID: 29707144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome.
    Konopka B; Szafron LM; Kwiatkowska E; Podgorska A; Zolocinska A; Pienkowska-Grela B; Dansonka-Mieszkowska A; Balcerak A; Lukasik M; Stachurska A; Timorek A; Spiewankiewicz B; El-Bahrawy M; Kupryjanczyk J
    Oncotarget; 2016 Oct; 7(41):67412-67424. PubMed ID: 27602952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of EMSY gene in sporadic ovarian cancer.
    Altinisik J; Karateke A; Coksuer H; Ulutin T; Buyru N
    Mol Biol Rep; 2011 Jan; 38(1):359-63. PubMed ID: 20349280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amplification of EMSY gene in a subset of sporadic pancreatic adenocarcinomas.
    van Hattem WA; Carvalho R; Li A; Offerhaus GJ; Goggins M
    Int J Clin Exp Pathol; 2008 Jan; 1(4):343-51. PubMed ID: 18787609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical study of topotecan and cisplatin as first line chemotherapy in epithelial ovarian cancer].
    Meng LH; Kong BH; Zhang YZ; Yang XS; Wang LJ; Su SL; Jiang J; Cui BX; Wang B
    Zhonghua Fu Chan Ke Za Zhi; 2007 Oct; 42(10):683-7. PubMed ID: 18241544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.